Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
Invasive fungal infection (IFI) is a leading cause of infection-related mortality among patients with cancer and prolonged neutropenia and among allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease. Invasive candidiasis was the principal IFI in the period predating fluconazole prophylaxis, whereas today, invasive aspergillosis and other mold infections cause the majority of deaths from fungal infection in this patient population. The changing epidemiology of IFI, in addition to advances made in antifungal therapeutics and early diagnosis of IFI, warrant a reevaluation of earlier strategies aimed at prevention and early treatment of IFI that were developed several years ago. Here, we propose that persistent neutropenic fever is nonspecific for an IFI and should not be used as the sole criterion for empirical modification in the antifungal regimen in a patient receiving mold-active prophylaxis. We explore the potential benefits and gaps in knowledge associated with employing chest CT scans and laboratory markers as diagnostic adjuncts for IFI. Finally, we discuss the implications of newer antifungal agents and diagnostic adjuncts in the design of future clinical trials to evaluate prophylaxis and early prevention strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, antifungal prophylaxis is now routinely used for extremely premature newborns in some neonatal units and for patients with certain types of hematologic malignancies, dramatically reducing rates of candidemia in these populations (15,16).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [15]
In the citing paper
“This might be due to increasing use of antifungal prophylactic regimens among patients with leukemia or lymphoma, patients who received bone marrow transplants, and chemotherapy recipients (15).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [15]
Citations
Cites
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331
Self-citationApoptosis. Its significance in cancer and cancer Therapy
Kerr, J. F. R., Winterford, C. M., & HARMON, B. V. (1994) · Cancer · doi:10.1002/1097-0142(19940415)73:8<2157::aid-cncr2820730821>3.0.co;2-1 · Cited by 2,135
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
Marr, K. A., Carter, R. A., Crippa, F., Wald, A., & Corey, L. (2002) · Clinical Infectious Diseases · doi:10.1086/339202 · Cited by 1,448
Assessing symptom distress in cancer patients: The M. D. Anderson Symptom Inventory
Cleeland, C. S., Mendoza, T. R., Wang, X. S., Chou, C., Harle, M. T., Morrissey, M., & Engstrom, M. C. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1634::aid-cncr29>3.0.co;2-v · Cited by 1,360
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Self-citationGoodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979 · cited 1×
“gin with liposomal amphotericin B, the proportion of patients with a successful outcome in the different treatment arms was 26%–34% [29, 30].”
BackgroundSelf-citationDiagnosis of Invasive Aspergillosis Using a Galactomannan Assay: A Meta-Analysis
Pfeiffer, C. D., Fine, J. P., & Safdar, N. (2006) · Clinical Infectious Diseases · doi:10.1086/503427 · Cited by 962
Marr, K. A., Carter, R. A., Boeckh, M., Martin, P., & Corey, L. (2002) · Blood · doi:10.1182/blood-2002-05-1496 · Cited by 957
Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszynska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 919
Self-citationPizzo, P. A., Robichaud, K. J., Gill, F. A., & Witebsky, F. G. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90594-0 · Cited by 859
Slavin, M. A., Osborne, B., Adams, R., Levenstein, M. J., Schoch, H. G., Feldman, A. R., Meyers, J. D., & Bowden, R. A. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1545 · Cited by 820
Walsh, T. J., Raad, I., Patterson, T. F., Chandrasekar, P., Donowitz, G. R., Graybill, R., Greene, R. E., Hachem, R., Hadley, S., Herbrecht, R., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/508774 · Cited by 752
Self-citationvan Burik, J.-A. H., Ratanatharathorn, V., Stepan, D. E., Miller, C. B., Lipton, J. H., Vesole, D. H., Bunin, N., Wall, D. A., Hiemenz, J. W., Satoi, Y., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/422312 · Cited by 744
Self-citationWald, A., Leisenring, W., van Burik, J., & Bowden, R. A. (1997) · The Journal of Infectious Diseases · doi:10.1086/516480 · Cited by 742 · cited 2×
“sive aspergillosis (IA) [1–3] and less com-”
Kontoyiannis, D. P., Lionakis, M. S., Lewis, R. E., Chamilos, G., Healy, M., Perego, C., Safdar, A., Kantarjian, H., Champlin, R., Walsh, T. J., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428780 · Cited by 674
Self-citationSchimpff, S., Satterlee, W., Young, V. M., & Serpick, A. (1971) · New England Journal of Medicine · doi:10.1056/nejm197105132841904 · Cited by 673
Ostrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432470 · Cited by 669 · cited 1×
“with use of the b-glucan assay in HSCT recipients is limited [70], and the use of”
MethodSelf-citationOdabasi, Z., Mattiuzzi, G., Estey, E., Kantarjian, H., Saeki, F., Ridge, R. J., Ketchum, P. A., Finkelman, M. A., Rex, J. H., & Ostrosky-Zeichner, L. (2004) · Clinical Infectious Diseases · doi:10.1086/421944 · Cited by 642
Infections due to emerging and uncommon medically important fungal pathogens
Walsh, T. J., Groll, A., Hiemenz, J., Fleming, R., Roilides, E., & Anaissie, E. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1470-9465.2004.00839.x · Cited by 601
Self-citationMaertens, J., Theunissen, K., Verhoef, G., Verschakelen, J., Lagrou, K., Verbeken, E., Wilmer, A., Verhaegen, J., Boogaerts, M., & Eldere, J. V. (2005) · Clinical Infectious Diseases · doi:10.1086/496927 · Cited by 592
Boutati, E. I., & Anaissie, E. J. (1997) · Blood · doi:10.1182/blood.v90.3.999 · Cited by 587
Posaconazole as Salvage Therapy for Zygomycosis
Greenberg, R. N., Mullane, K., van Burik, J.-A. H., Raad, I., Abzug, M. J., Anstead, G., Herbrecht, R., Langston, A., Marr, K. A., Schiller, G., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.126-133.2006 · Cited by 555
Self-citationMarr, K. A., Seidel, K., White, T. C., & Bowden, R. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315193 · Cited by 493
Marr, K. A., Balajee, S. A., McLaughlin, L., Tabouret, M., Bentsen, C., & Walsh, T. J. (2004) · The Journal of Infectious Diseases · doi:10.1086/422009 · Cited by 483
Self-citationDetection of circulating galactomannan for the diagnosis and management of invasive aspergillosis
Mennink-Kersten, M. A., Donnelly, J. P., & Verweij, P. E. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01045-x · Cited by 482
Chamilos, G., Luna, M. A., Lewis, R. E., Bodey, G. P., Chemaly, R. F., Tarrand, J. J., Safdar, A., RAAD, I. I., & Kontoyiannis, D. P. (2006) · PubMed · Cited by 479
Antifungal Therapy Decreases Sensitivity of theAspergillus Galactomannan Enzyme Immunoassay
Marr, K. A., Laverdiere, M., Gugel, A., & Leisenring, W. (2005) · Clinical Infectious Diseases · doi:10.1086/429921 · Cited by 471
Marr, K. A., Crippa, F., Leisenring, W., Hoyle, M., Boeckh, M., Balajee, S. A., Nichols, W. G., Musher, B., & Corey, L. (2004) · Blood · doi:10.1182/blood-2003-08-2644 · Cited by 442
Marty, F. M., Cosimi, L. A., & Baden, L. R. (2004) · New England Journal of Medicine · doi:10.1056/nejm200402263500923 · Cited by 426
Breakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving Voriconazole
Imhof, A., Balajee, S. A., Fredricks, D. N., Englund, J. A., & Marr, K. A. (2004) · Clinical Infectious Diseases · doi:10.1086/423274 · Cited by 402
Treatment of Invasive Aspergillosis: Relation of Early Diagnosis and Treatment to Response
AISNER, J., SCHIMPFF, S. C., & WIERNIK, P. H. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-86-5-539 · Cited by 397
Aspergillus Galactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer Patients
Herbrecht, R., Letscher-Bru, V., Oprea, C., Lioure, B., Waller, J., Campos, F., Villard, O., Liu, K.-L., Natarajan-Amé, S., Lutz, P., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.004 · Cited by 392
Self-citationWinston, D. J., Maziarz, R. T., Chandrasekar, P. H., Lazarus, H. M., Goldman, M., Blumer, J. L., Leitz, G. J., & Territo, M. C. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-9-200305060-00006 · Cited by 389
Empiric antifungal therapy in febrile granulocytopenic patients
(1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90441-5 · Cited by 378
Invasive Mold Infections in Allogeneic Bone Marrow Transplant Recipients
Baddley, J. W., Stroud, T. P., Salzman, D., & Pappas, P. G. (2001) · Clinical Infectious Diseases · doi:10.1086/319985 · Cited by 364
Fusarium Infection in Hematopoietic Stem Cell Transplant Recipients
Nucci, M., Marr, K. A., Queiroz-Telles, F., Martins, C. A., Trabasso, P., Costa, S., Voltarelli, J. C., Colombo, A. L., Imhof, A., Pasquini, R., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/383319 · Cited by 333
Boogaerts, M., Winston, D. J., Bow, E. J., Garber, G., Reboli, A. C., Schwarer, A. P., Novitzky, N., Boehme, A., Chwetzoff, E., De Beule, K., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00010 · Cited by 321
CAUSES OF DEATH IN ADULTS WITH ACUTE LEUKEMIA
CHANG, H.-Y., RODRIGUEZ, V., NARBONI, G., BODEY, G. P., LUNA, M. A., & FREIREICH, E. J. (1976) · Medicine · doi:10.1097/00005792-197605000-00005 · Cited by 301
Posaconazole: a broad-spectrum triazole antifungal
Torres, H. A., Hachem, R. Y., Chemaly, R. F., Kontoyiannis, D. P., & Raad, I. I. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70297-8 · Cited by 285
Empirical antifungal therapy in febrile granulocytopenic patients
Meunier, F. (1989) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · Cited by 268
Rotstein, C., Bow, E. J., Laverdiere, M., Ioannou, S., Carr, D., Moghaddam, N., & The Canadian Fluconazole Prophylaxis Study Group (1999) · Clinical Infectious Diseases · doi:10.1086/515128 · Cited by 265
Bow, E. J., Laverdière, M., Lussier, N., Rotstein, C., Cheang, M. S., & Ioannou, S. (2002) · Cancer · doi:10.1002/cncr.10610 · Cited by 258
Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients
Jantunen, E., Ruutu, P., Niskanen, L., Volin, L., Parkkali, T., Koukila-Kähkölä, P., & Ruutu, T. (1997) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1700737 · Cited by 251
Activity of posaconazole in the treatment of central nervous system fungal infections
Pitisuttithum, P., Negroni, R., Graybill, J. R., Bustamante, B., Pappas, P., Chapman, S., Hare, R. S., & Hardalo, C. J. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki288 · Cited by 251
Mortality and Cancer Incidence Among Individuals With Down Syndrome
Hill, D. A., Gridley, G., Cnattingius, S., Mellemkjaer, L., Linet, M., Adami, H.-O., Olsen, J. H., Nyren, O., & Fraumeni, J. F. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.6.705 · Cited by 247
Sulahian, A., Touratier, S., & Ribaud, P. (2003) · New England Journal of Medicine · doi:10.1056/nejm200312113492424 · Cited by 237
van Burik, J.-A. H., Leisenring, W., Myerson, D., Hackman, R. C., Shulman, H. M., Sale, G. E., Bowden, R. A., & McDonald, G. B. (1998) · Medicine · doi:10.1097/00005792-199807000-00003 · Cited by 205
Grow, W., Moreb, J., Roque, D., Manion, K., Leather, H., Reddy, V, Khan, S., Finiewicz, K., Nguyen, H., Clancy, C., et al. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703332 · Cited by 192
Self-citationCyclophosphamide metabolism is affected by azole antifungals
Marr, K. A., Leisenring, W., Crippa, F., Slattery, J. T., Corey, L., Boeckh, M., & McDonald, G. B. (2004) · Blood · doi:10.1182/blood-2003-07-2512 · Cited by 190
Winston, D. J., Hathorn, J. W., Schuster, M. G., Schiller, G. J., & Territo, M. C. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00457-x · Cited by 189
McWhinney, P. H. M., Kibbler, C. C., Hamon, M. D., Smith, O. P., Gandhi, L., Berger, L. A., Walesby, R. K., Hoffbrand, A. V., & Prentice, H. G. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.3.397 · Cited by 187
Petraitiene, R., Petraitis, V., Groll, A. H., Sein, T., Piscitelli, S., Candelario, M., Field-Ridley, A., Avila, N., Bacher, J., & Walsh, T. J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.857-869.2001 · Cited by 179
Self-citationVazquez, J. A., Skiest, D. J., Nieto, L., Northland, R., Sanne, I., Gogate, J., Greaves, W., & Isaacs, R. (2006) · Clinical Infectious Diseases · doi:10.1086/501457 · Cited by 171
Segal, B. H., Barnhart, L. A., Anderson, V. L., Walsh, T. J., Malech, H. L., & Holland, S. M. (2005) · Clinical Infectious Diseases · doi:10.1086/430068 · Cited by 163
Self-citationWalsh, T. J., Shoham, S., Petraitiene, R., Sein, T., Schaufele, R., Kelaher, A., Murray, H., Mya-San, C., Bacher, J., & Petraitis, V. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4744-4748.2004 · Cited by 151
Self-citationPfaller, M. A., Messer, S. A., Hollis, R. J., & Jones, R. N. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2862-2864.2001 · Cited by 143
Kanda, Y., Yamamoto, R., Chizuka, A., Hamaki, T., Suguro, M., Arai, C., Matsuyama, T., Takezako, N., Miwa, A., Kern, W., et al. (2000) · PubMed · Cited by 137
Bodey, G. P., Anaissie, E. J., Elting, L. S., Estey, E., O'Brien, S., & Kantarjian, H. (1994) · Cancer · doi:10.1002/1097-0142(19940415)73:8<2099::aid-cncr2820730814>3.0.co;2-n · Cited by 131
Kanda, Y., Yamamoto, R., Chizuka, A., Hamaki, T., Suguro, M., Arai, C., Matsuyama, T., Takezako, N., Miwa, A., Kern, W., et al. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1611::aid-cncr27>3.0.co;2-b · Cited by 128
Viscoli, C., Castagnola, E., Van Lint, M. T., Moroni, C., Garaventa, A., Rossi, M. R., Fanci, R., Menichetti, F., Caselli, D., Giacchino, M., et al. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00619-2 · Cited by 122
Rapid diagnosis of invasive aspergillosis by antigen detection
Wheat, L. J. (2003) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2003.00031.x · Cited by 116
Pfaller, M. A., Messer, S. A., Mills, K., & Bolmström, A. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.9.3359-3361.2000 · Cited by 100
Yuen, K., Woo, P. C. Y., Ip, M. S. M., Liang, R. H. S., Chiu, E. K. W., Siau, H., Ho, P., Chen, F. F. E., & Chan, T. (1997) · Clinical Infectious Diseases · doi:10.1086/514492 · Cited by 83
Shaukat, A., Bakri, F. G., Young, P. M., Hahn, T., Ball, D., Baer, M. R., Wetzler, M., Slack, J. L., Loud, P. A., Czuczman, M. S., et al. (2005) · Mycopathologia · doi:10.1007/s11046-004-5495-0 · Cited by 75
Self-citationIn Vitro and In Vivo Activities of Posaconazole against Coccidioides immitis
González, G. M., Tijerina, R., Najvar, L. K., Bocanegra, R., Rinaldi, M., Loebenberg, D., & Graybill, J. R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1352-1356.2002 · Cited by 69
Jahagirdar, B., & Morrison, V. A. (2002) · Seminars in Respiratory Infections · doi:10.1053/srin.2002.33446 · Cited by 59
Bennett, J. E., Powers, J. H., Walsh, T. J., Viscoli, C., de Pauw, B., Dismukes, W. E., Galgiani, J. N., Glauser, M. P., Herbrecht, R., Kauffman, C. A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/367839 · Cited by 57
Self-citationKontoyiannis, D. P., Bodey, G., Hanna, H. A., Hachem, R. Y., Boktour, M. R., GIRGAWAY, E., Mardani, M., & RAAD, I. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000149386 · Cited by 52
Pfaller, M. A., Messer, S. A., Boyken, L. B., Hollis, R. J., & Diekema, D. J. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00544-8 · Cited by 48
Mattiuzzi, G. N., Kantarjian, H., Faderl, S., Lim, J., Kontoyiannis, D., Thomas, D., Wierda, W., Raad, I., Garcia‐Manero, G., Zhou, X., et al. (2004) · Cancer · doi:10.1002/cncr.11936 · Cited by 46
Pauw, B. E. D., Sable, C. A., Walsh, T. J., Lupinacci, R. J., Bourque, M. R., Wise, B. A., Nguyen, B., DiNubile, M. J., & Teppler, H. (2006) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2006.00127.x · Cited by 32
Self-citationPizzo, P. A. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7216-9131-2.50062-2 · Cited by 23
Cornely, O. A., Maertens, J. A., Winston, D. J., Perfect, J. R., HELFGOTT, D. C., Ullmann, A. J., Hołowiecki, J., Stockelberg, D., Goh, Y. T., Petrini, M., et al. (2005) · Blood · doi:10.1182/blood.v106.11.1844.1844 · Cited by 20
Self-citationWingard, J. R. (2004) · Clinical Infectious Diseases · doi:10.1086/421953 · Cited by 18
Self-citationAntifungal therapy for febrile neutropenia: issues in clinical trial design.
Marr, K. A. (2004) · PubMed · Cited by 6
Research works printed but not linked: 5
- AISNER, 1977, Annals of Internal Medicine, 86, 539, 10.1059/0003-4819-86-5-539 · doi:10.1059/0003-4819-86-5-539
- -1, Journal of Infectious Diseases, -1, MASTER, 10.1093/jnlids/171.6.1545 · doi:10.1093/jnlids/171.6.1545
- Marr, 2004, Current opinion in investigational drugs (London, England : 2000), 5, 202
- 2003, Blood, 2, 2
- 2003, Blood, 22, 22
Cited by
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Self-citationPappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
“The usefulness of other potentially active agents, such as itraconazole and AmB, in stem cell transplant recipients is limited by toxicity, drug-drug interactions, logistical issues, or bioavailability [295].”
BackgroundSelf-citationPatterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Self-citationStevens, D. L., Bisno, A. L., Chambers, H. F., Dellinger, E. P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, S. L., Montoya, J. G., & Wade, J. C. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu296 · Cited by 2,780
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,706
Self-citation
Metadata
- Authors
- Segal, B. H., Almyroudis, N. G., Battiwalla, M., Herbrecht, R., Perfect, J. R., Walsh, T. J., & Wingard, J. R.
- Affiliations
- Roswell Park Comprehensive Cancer Center (US)
- Hôpitaux Universitaires de Strasbourg (FR)
- Duke Medical Center (US)
- National Institutes of Health (US)
- University of Florida (US)
- Corresponding author
- Segal, B. H.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-02-01
- Volume
- 44
- Issue
- 3
- Pages
- 402-409
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2134986902
- Cited by
- 168
- References
- 77
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 6 · 2017: 3 · 2016: 5 · 2015: 6 · 2014: 11 · 2013: 10 · 2012: 8
- FWCI
- 16.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- invasive fungal infections, invasive candidiasis, invasive aspergillosis, mold infections, cancer patients, neutropenia, hematopoietic stem cell transplantation, graft-versus-host disease, antifungal prophylaxis, fluconazole, chest CT, laboratory biomarkers, early diagnosis, antifungal agents, clinical trial design
- MeSH terms
- Antifungal Agents, Evaluation Studies as Topic, Fever, Fungi, Galactose, Humans, Mannans, Mycoses, Neoplasms, Neutropenia, Tomography, X-Ray Computed, Yeasts, Biomarkers, Randomized Controlled Trials as Topic, Practice Guidelines as Topic, Hematopoietic Stem Cell Transplantation, beta-Glucans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.